These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21514400)

  • 1. Suitable top concentration for tests with mammalian cells: mouse lymphoma assay workgroup.
    Moore MM; Honma M; Clements J; Awogi T; Douglas GR; van Goethem F; Gollapudi B; Kimura A; Muster W; O'Donovan M; Schoeny R; Wakuri S
    Mutat Res; 2011 Aug; 723(2):84-6. PubMed ID: 21514400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse lymphoma thymidine kinase gene mutation assay: follow-up International Workshop on Genotoxicity Test Procedures, New Orleans, Louisiana, April 2000.
    Moore MM; Honma M; Clements J; Harrington-Brock K; Awogi T; Bolcsfoldi G; Cifone M; Collard D; Fellows M; Flanders K; Gollapudi B; Jenkinson P; Kirby P; Kirchner S; Kraycer J; McEnaney S; Muster W; Myhr B; O'Donovan M; Oliver J; Ouldelhkim MC; Pant K; Preston R; Riach C; San R; Shimada H; Stankowski LF
    Environ Mol Mutagen; 2002; 40(4):292-9. PubMed ID: 12489120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse lymphoma thymidine kinase gene mutation assay: meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005, recommendations for 24-h treatment.
    Moore MM; Honma M; Clements J; Bolcsfoldi G; Burlinson B; Cifone M; Clarke J; Clay P; Doppalapudi R; Fellows M; Gollapudi B; Hou S; Jenkinson P; Muster W; Pant K; Kidd DA; Lorge E; Lloyd M; Myhr B; O'Donovan M; Riach C; Stankowski LF; Thakur AK; Van Goethem F;
    Mutat Res; 2007 Feb; 627(1):36-40. PubMed ID: 17157054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of published data for top concentration considerations in mammalian cell genotoxicity testing.
    Parry JM; Parry E; Phrakonkham P; Corvi R
    Mutagenesis; 2010 Nov; 25(6):531-8. PubMed ID: 20720196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of U. S. National Toxicology Program (NTP) mouse lymphoma assay data using International Workshop on Genotoxicity Tests (IWGT) and the Organization for Economic Co-Operation and Development (OECD) criteria.
    Schisler MR; Gollapudi BB; Moore MM
    Environ Mol Mutagen; 2018 Dec; 59(9):829-841. PubMed ID: 30357906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse lymphoma thymidine kinase gene mutation assay: International Workshop on Genotoxicity Tests Workgroup report--Plymouth, UK 2002.
    Moore MM; Honma M; Clements J; Bolcsfoldi G; Cifone M; Delongchamp R; Fellows M; Gollapudi B; Jenkinson P; Kirby P; Kirchner S; Muster W; Myhr B; O'Donovan M; Oliver J; Omori T; Ouldelhkim MC; Pant K; Preston R; Riach C; San R; Stankowski LF; Thakur A; Wakuri S; Yoshimura I;
    Mutat Res; 2003 Oct; 540(2):127-40. PubMed ID: 14550497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse lymphoma thymidine kinase gene mutation assay: follow-up meeting of the International Workshop on Genotoxicity Testing--Aberdeen, Scotland, 2003--Assay acceptance criteria, positive controls, and data evaluation.
    Moore MM; Honma M; Clements J; Bolcsfoldi G; Burlinson B; Cifone M; Clarke J; Delongchamp R; Durward R; Fellows M; Gollapudi B; Hou S; Jenkinson P; Lloyd M; Majeska J; Myhr B; O'Donovan M; Omori T; Riach C; San R; Stankowski LF; Thakur AK; Van Goethem F; Wakuri S; Yoshimura I
    Environ Mol Mutagen; 2006 Jan; 47(1):1-5. PubMed ID: 15991242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations on photochemical genotoxicity. II: report of the 2009 International Workshop on Genotoxicity Testing Working Group.
    Lynch AM; Guzzie PJ; Bauer D; Gocke E; Itoh S; Jacobs A; Krul CA; Schepky A; Tanaka N; Kasper P
    Mutat Res; 2011 Aug; 723(2):91-100. PubMed ID: 21296679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up testing of rodent carcinogens not positive in the standard genotoxicity testing battery: IWGT workgroup report.
    Kasper P; Uno Y; Mauthe R; Asano N; Douglas G; Matthews E; Moore M; Mueller L; Nakajima M; Singer T; Speit G;
    Mutat Res; 2007 Feb; 627(1):106-16. PubMed ID: 17123861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus).
    Galloway S; Lorge E; Aardema MJ; Eastmond D; Fellows M; Heflich R; Kirkland D; Levy DD; Lynch AM; Marzin D; Morita T; Schuler M; Speit G
    Mutat Res; 2011 Aug; 723(2):77-83. PubMed ID: 21255675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriate levels of cytotoxicity for genotoxicity tests using mammalian cells in vitro.
    Müller L; Sofuni T
    Environ Mol Mutagen; 2000; 35(3):202-5. PubMed ID: 10737955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse lymphoma thymidine kinase locus gene mutation assay: International Workshop on Genotoxicity Test Procedures Workgroup Report.
    Moore MM; Honma M; Clements J; Awogi T; Bolcsfoldi G; Cole J; Gollapudi B; Harrington-Brock K; Mitchell A; Muster W; Myhr B; O'Donovan M; Ouldelhkim MC; San R; Shimada H; Stankowski LF
    Environ Mol Mutagen; 2000; 35(3):185-90. PubMed ID: 10737953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing.
    Rothfuss A; Honma M; Czich A; Aardema MJ; Burlinson B; Galloway S; Hamada S; Kirkland D; Heflich RH; Howe J; Nakajima M; O'Donovan M; Plappert-Helbig U; Priestley C; Recio L; Schuler M; Uno Y; Martus HJ
    Mutat Res; 2011 Aug; 723(2):108-20. PubMed ID: 21182982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of positive results in the mouse lymphoma TK assay (MLA) in pharmaceutical screening and their prediction by MultiCase MC4PC.
    Fellows MD; Boyer S; O'Donovan MR
    Mutagenesis; 2011 Jul; 26(4):529-32. PubMed ID: 21430064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GADD45a-GFP GreenScreen HC assay results for the ECVAM recommended lists of genotoxic and non-genotoxic chemicals for assessment of new genotoxicity tests.
    Birrell L; Cahill P; Hughes C; Tate M; Walmsley RM
    Mutat Res; 2010 Jan; 695(1-2):87-95. PubMed ID: 20006735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test.
    Hayashi M; MacGregor JT; Gatehouse DG; Blakey DH; Dertinger SD; Abramsson-Zetterberg L; Krishna G; Morita T; Russo A; Asano N; Suzuki H; Ohyama W; Gibson D;
    Mutat Res; 2007 Feb; 627(1):10-30. PubMed ID: 17157053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring.
    Hayashi M; MacGregor JT; Gatehouse DG; Adler ID; Blakey DH; Dertinger SD; Krishna G; Morita T; Russo A; Sutou S
    Environ Mol Mutagen; 2000; 35(3):234-52. PubMed ID: 10737958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.